kras mutation and glutathion glynac

kras mutation and glutathion glynac Targeting KRAS: from metabolic regulation to cancer treatment | Molecular Cancer Glutathione Depletion and Stalwart Anticancer

Name: kras mutation and glutathion glynac Targeting KRAS: from metabolic regulation to cancer treatment | Molecular Cancer Glutathione Depletion and Stalwart Anticancer
Brand: cantondelareina.com.ar
SKU: 57831769785
Price: 22.47 USD
Availability: InStock
Rating: 4.774900000000001 (26 reviews)

Glutathione Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy ACS Omega Oncometabolites in pancreatic cancer: Strategies and its implications PMC Metabonomics study of the effects of single copy mutant KRAS in the presence or absence of WT allele using human HCT116 isogenic cell lines Metabolomics Springer Nature Link The Metabolic Landscape of RAS Driven Cancers from biology to therapy PMC

SKU: 57831769785 · From cantondelareina.com.ar

4.8

USD22.47 USD49.47

Pay in 4 interest-free payments of $5.62 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 14 - Sep 19

Description

confirmed that TFAP2C regulated GPx1 expression by directly binding to the GPx1 promoter, which contains an AP-2 regulatory region, and the methylation of the CpG island in the GPx1 promoter region prevented the binding of TFAP2C by encompassing the AP-2 regulatory region [81]